No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
SAUDI ARABIA – The Kingdom of Saudi Arabia has hosted the 2nd Riyadh Global Medical Biotechnology Summit (RGMBS 2023) at the Hilton Hotel in Riyadh. The Riyadh Global Medical Biotechnology…
Read More
SAUDI ARABIA – The Kingdom of Saudi Arabia is ready to host an annual international conference focused on medical devices regulation at the Crowne Plaza Riyadh RDC Hotel & Convention…
Read More
UAE – Mubadala Investment Company (Mubadala) has signed an agreement with National Resilience Inc., a first-of-its-kind manufacturing and technology company, to bolster the life science industry in the United Arab…
Read More
SAUDI ARABIA – Celularity Inc., a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC have entered into an exclusive distribution agreement with…
Read More
SWITZERLAND –Commercial-stage biotechnology company ADC Therapeutics has elected industry veteran Mohamed Zaki, MD, Ph.D., as its new Chief Medical Officer (CMO), effective January 3, 2023. He succeeds Sridhar Venkatesh, Dr.…
Read More
KENYA – Kenya’s Ministry of Health has secured digital non-mydriatic research equipment from multinational pharmaceutical company AstraZeneca that uses retinal cameras to analyze the risk of a patient having or…
Read More
NIGERIA – The Lagos State Government in Nigeria has announced plans to open an advanced highly infectious disease research institute and permanent isolation facilities at Yaba before end of 2022…
Read More
KENYA – The International Centre for Genetic Engineering and Biotechnology (ICGEB) has appointed Kenya as the host of its first Regional Research Centre (RRC) in Africa dedicated to advanced research…
Read More
SOUTH AFRICA – South African pharmaceutical company Biotech Africa has been awarded a non-exclusive sublicence that allows the company to manufacture and commercialize Spain’s National Research Council’s (CSIC) COVID-19 serological…
Read More
DENMARK – The European Commission has granted marketing authorization of Lundbeck’s anti-Calcitonin Gene Related Protein (Anti-CGRP) antibody Vyepti (eptinezumab) in the European Union (EU) for the prophylactic treatment of migraine…
Read More